We are live on ! Find out more
BSX icon

Boston Scientific

1,512 hedge funds and large institutions have $120B invested in Boston Scientific in 2024 Q4 according to their latest regulatory filings, with 218 funds opening new positions, 617 increasing their positions, 489 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 218 | Existing positions closed: 83

26% more repeat investments, than reductions

Existing positions increased: 617 | Existing positions reduced: 489

9% more capital invested

Capital invested by funds: $111B → $120B (+$9.45B)

8% more funds holding

Funds holding: 1,3951,512 (+117)

8% more funds holding in top 10

Funds holding in top 10: 3639 (+3)

1.08% more ownership

Funds ownership: 89.89%90.98% (+1.1%)

13% less call options, than puts

Call options by funds: $797M | Put options by funds: $912M

Holders
1,512
Holders Change
+117
Holders Change %
+8.39%
% of All Funds
19.92%
Holding in Top 10
39
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+8.33%
% of All Funds
0.51%
New
218
Increased
617
Reduced
489
Closed
83
Calls
$797M
Puts
$912M
Net Calls
-$115M
Net Calls Change
+$168M
Name Holding Trade Value Shares
Change
Change in
Stake
SFM
401
Soros Fund Management
New York
$8.93M -$22M -250,001 -71%
SLI
402
Sumitomo Life Insurance
Japan
$8.92M +$889K +10,098 +11%
KCM
403
Kennedy Capital Management
Missouri
$8.89M +$1.82M +20,635 +26%
LSA
404
L & S Advisors
California
$8.82M +$1.51M +17,191 +21%
CSS
405
Cubist Systematic Strategies
Connecticut
$8.75M +$5.28M +59,950 +158%
BPWM
406
Badgley Phelps Wealth Managers
Washington
$8.71M +$806K +9,161 +10%
BHCM
407
Brevan Howard Capital Management
Jersey
$8.69M +$5.68M +64,489 +196%
MYAM
408
Meiji Yasuda Asset Management
Japan
$8.62M +$1.42M +16,184 +20%
AG
409
AIA Group
Hong Kong
$8.6M +$8.09M +91,868 +2,067%
Dodge & Cox
410
Dodge & Cox
California
$8.47M -$44K -500 -0.5%
CGH
411
Crossmark Global Holdings
Texas
$8.36M -$45.5K -517 -0.5%
HIMCH
412
Hartford Investment Management Co (HIMCO)
Connecticut
$8.15M -$129K -1,470 -2%
AF
413
Alerus Financial
North Dakota
$8.07M -$634K -7,207 -7%
NRI
414
NFP Retirement Inc
California
$8.03M
CDDEC
415
Caisse Des Depots Et Consignations
France
$7.96M +$7.84M +89,102 New
NA
416
NewEdge Advisors
Louisiana
$7.94M +$477K +5,416 +6%
HC
417
Headland Capital
South Carolina
$7.94M +$7.82M +88,886 New
RBI
418
Raiffeisen Bank International
Austria
$7.94M +$7.79M +88,496 New
KOCAA
419
Knights of Columbus Asset Advisors
Connecticut
$7.79M -$11.5K -131 -0.1%
AAIS
420
ABN AMRO Investment Solutions
$7.79M +$560K +6,366 +8%
EFM
421
E Fund Management
China
$7.76M +$2.93M +33,274 +62%
CM
422
Cercano Management
Washington
$7.67M -$18.7M -212,263 -71%
ACM
423
Atika Capital Management
New York
$7.61M +$7.5M +85,200 New
CRCM
424
Crystal Rock Capital Management
Illinois
$7.6M -$566K -6,425 -7%
SSA
425
Schonfeld Strategic Advisors
New York
$7.54M -$9.72M -110,449 -57%

BSX Hedge Fund Activity: Q4 2024 in Review

1,512 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2024, worth a combined $120B — up 8.5% from $111B a quarter earlier.

Buyers outnumbered sellers: 218 funds opened new BSX positions and 83 closed out — a net gain of 135 holders — while 617 added to existing stakes and 489 trimmed.

The largest buyer was BlackRock, adding an estimated $909M. The largest seller was Massachusetts Financial Services, cutting an estimated $529M.

  • 1,512 institutional investors held Boston Scientific (BSX) as of Q4 2024, up from 1,395 in Q3 2024.
  • Funds reported $120B of Boston Scientific stock for Q4 2024, up 8.5% quarter-over-quarter.
  • 218 funds opened new Boston Scientific positions in Q4 2024 and 83 closed out, a net change of +135 holders.
  • The largest Boston Scientific buyer in Q4 2024 was BlackRock, an estimated $909M added.
  • The largest Boston Scientific seller in Q4 2024 was Massachusetts Financial Services, an estimated $529M sold.

Based on aggregated 13F filings for Q4 2024.